Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stanford Researchers Find Protein Targets for Potential Treatment of Multiple Sclerosis

Published: Monday, February 18, 2008
Last Updated: Monday, February 18, 2008
Bookmark and Share
Stanford researchers have identified therapy targets that could lead to personalized treatments for MS patients at each phase of the illness.

Multiple sclerosis is not a single condition, but an ebbing and flowing of stages affecting the body’s central nervous system. Recognizing that pattern, researchers from the Stanford University School of Medicine have identified therapy targets that could lead to personalized treatments for patients at each phase of the illness.

Essentially, the team cataloged all of the brain-tissue proteins that they found were distinct to three discrete stages of multiple sclerosis.

“This is a gold mine,” said Lawrence Steinman, MD, professor of neurology and neurological sciences. “Knowing what proteins are most important at a discrete stage of the multiple sclerosis process is the first step toward being able to ‘personalize’ treatment.”

Steinman, whose team worked with researchers at the University of Connecticut Health Center, is one of two senior authors of the article that will be published in the Feb. 17 issue of the journal Nature.

In the study, the team found many unexpected proteins involved in the disease progression. When they tested drugs that block two of these proteins in a mouse model of multiple sclerosis, the mice improved dramatically.

“If our hypothesis is correct, the findings can be directly applied to patients,” said May Han, MD, a postdoctoral scholar at Stanford and co-first author of the paper. She emphasized that researchers are still very early in the process of being able to tailor drug therapies for humans.

In multiple sclerosis, the immune system launches an attack against the myelin sheath surrounding nerve cells, causing them to misfire. The resulting variety of neurological disorders affects more than 2.5 million people worldwide, according to the Multiple Sclerosis International Federation.

When Han arrived to work in Steinman’s lab, she suggested studying the amazing repository of multiple sclerosis brain samples still being stored in the lab freezer. The samples had come from Cedric Raine, MD, professor of pathology and of neurology at the Albert Einstein College of Medicine, who had collaborated six years ago with Steinman. Raine had obtained the samples from autopsies of patients with various stages of multiple sclerosis, and he had supplied a detailed analysis of the abnormalities.

Han proposed a novel idea: to use these carefully characterized slices to identify the protein changes between three major types of multiple sclerosis lesions seen upon autopsy—plaques from the acute stage (recent inflammation and damage to myelin), the chronic-active stage (long-term myelin damage and areas of recent inflammation) and the chronic-silent stage (no current inflammation).

Steinman recalled telling Han that it was a great idea, but that his lab didn’t do proteomics, which is the large-scale study of protein structure and function. But Han had a secret weapon: Her brother, David Han, PhD, directs a proteomics analysis facility at the University of Connecticut Health Center. He is the other senior author of the paper.

They identified more than 1,000 different proteins in each stage, creating the largest catalog of multiple sclerosis brain lesions to date. The enormous list of proteins became a bottleneck for the researchers. They used a computer program to identify which proteins are only present in each stage and came up with hundreds of unique proteins for each stage.

They picked two of the proteins found in the chronic-active phase for further exploration: tissue factor, which is involved in the coagulation of blood, and protein C inhibitor, which blocks the anticoagulant protein C. They chose these proteins for several reasons, including the fact that there are FDA-approved drugs that block those proteins, which would allow the researchers to tease apart what was happening.

Also, said Steinman, it was fascinating to explore these drugs, usually used for people with blood clots or hemorrhaging, in the completely different context of a role in a nervous system disorder.

Mice with the symptoms of multiple sclerosis showed improvement in the severity of their disease after being given drugs that block either tissue factor or protein C inhibitor. But treating a mouse is a far cry from helping humans.

“One of the stumbling blocks on this path to personalized medicine is that our samples came from multiple sclerosis brains,” said Steinman. “Ordinarily, one doesn’t stick a needle into a multiple sclerosis brain.” He said there are some intriguing leads from other publications that suggest some of the proteins they found could be detected in cerebrospinal fluid.

“If a person had in their spinal fluid, using our findings as an example, an elevated level of protein C inhibitor, then a doctor could come into the room and say, ‘We have a medicine that will fit you perfectly,’” Steinman said.

This work was funded by the National Institute of Health and the National Multiple Sclerosis Society. Others from Stanford who contributed to this study are: graduate student Jordan Price; postdoctoral scholar Shalina Ousman, PhD; William Robinson, MD, PhD, assistant professor of immunology and rheumatology, and Raymond Sobel, MD, professor of pathology.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Thursday, July 30, 2015
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Monday, July 27, 2015
A Protein's Novel Role In Several Types Of Cancers Discovered
Stanford ChEM-H scientists are helping to develop a novel cancer therapy based on a new finding of a protein that inadvertently promotes cancer growth.
Friday, February 27, 2015
Stanford Chemists Take Step Toward Solving Mystery of How Enzymes Work
Steven Boxer and his students have found that the electrostatic field within an enzyme accounts for the lion's share of its success.
Wednesday, December 24, 2014
Protein Complex May Play Role in Preventing Many Forms of Cancer, Study Shows
Researchers at the Stanford University School of Medicine have identified a group of proteins that are mutated in about one-fifth of all human cancers.
Tuesday, May 07, 2013
Scientists Identify Two Molecules that Affect Brain Plasticity in Mice
Stanford researchers have identified a set of molecular brakes that stabilize the developing brain’s circuitry.
Tuesday, December 01, 2009
Sequential Genomic Analysis Links Gene with Human Kidney Aging
The new approach that combines sequential transcriptional profiling and eQTL mapping, can help find other genetic associations.
Tuesday, October 27, 2009
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Self-Assembling, Biomimetic Membranes May Aid Water Filtration
A synthetic membrane that self assembles and is easily produced may lead to better gas separation, water purification, drug delivery and DNA recognition, according to an international team of researchers.
Crystal Clear Images Uncover Secrets of Hormone Receptors
NIH researchers gain better understanding of how neuropeptide hormones trigger chemical reactions in cells.
Error Correction Mechanism in Cell Division
Cell biologists have reported an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.
Crucial for Stem Cell Survival Protein Identified Using Editing Tool CRISPR
A team of University of Wisconsin-Madison engineers has identified a protein that is integral to the survival and self-renewal processes of human pluripotent stem cells (hPSC).
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!